Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · IEX Real-Time Price · USD

4.280

-0.040 (-0.93%)

At close: May 6, 2024, 4:00 PM

4.530

+0.250 (5.84%)

Pre-market: May 7, 2024, 8:31 AM EDT

Sagimet Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	137	124	-	-
Enterprise Value	42	29	-32	-56
PE Ratio	-4.45	-4.45	-	-
PS Ratio	68.30	62.05	-	-
PB Ratio	1.50	1.36	-	-
P/FCF Ratio	-5.22	-5.22	-	-
P/OCF Ratio	-5.22	-5.22	-	-
EV/Sales Ratio	20.88	14.63	-	-
EV/EBITDA Ratio	-1.06	-1.06	1.06	2.32
EV/EBIT Ratio	-1.05	-1.05	1.05	2.31
EV/FCF Ratio	-1.23	-1.23	1.31	2.60
Debt / Equity Ratio	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00	-0.01	-0.01
Debt / FCF Ratio	0.00	0.00	-0.01	-0.02
Quick Ratio	16.78	16.78	6.13	23.26
Current Ratio	17.09	17.09	6.21	24.04
Asset Turnover	0.03	0.03	0	-
Return on Equity (ROE)	55.20%	55.20%	17.70%	-
Return on Assets (ROA)	-44.90%	-44.90%	-66.30%	-
Return on Capital (ROIC)	-33.73%	-33.73%	16.63%	15.02%
Earnings Yield	-20.41%	-22.46%	-	-
FCF Yield	-17.40%	-19.15%	-	-
Buyback Yield / Dilution	-5565.90%	-5565.90%	98.11%	-
Total Shareholder Return	-5565.90%	-5565.90%	98.11%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).